The HARMONY Alliance consisted of two projects, HARMONY and HARMONY PLUS, both funded through the Innovative Health Initiative (IHI).
The EU grant phase has come to an end for HARMONY PLUS per March 2024.
The EU grant phase has come to an end for HARMONY per June 2023. For results, click here >
Thanks to the strong commitment and drive of our multi-stakeholder partners and members we have the unique opportunity to continue our work as a non-profit, collaborative research foundation. The new foundation will build upon the achievements of the HARMONY Alliance and bring hematology research and patient care to the next level.
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
